Tag #End-Stage Renal Disease

How does the use of CRISPR gene editing technology contribute to the success and potential of xenotransplantation?

The successful pig-to-human kidney transplant in Tim Andrews highlights the potential of xenotransplantation to address the critical organ shortage. This innovative approach uses gene editing to overcome organ rejection and compatibility issues, offering hope for the 80,000-100,000 patients annually awaiting kidney transplants. The procedure's success, through the FDA's Expanded Access pathway, opens doors for broader clinical trials and transformative treatment options.